John W. Boja

2.6k total citations
53 papers, 2.3k citations indexed

About

John W. Boja is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, John W. Boja has authored 53 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cellular and Molecular Neuroscience, 24 papers in Molecular Biology and 14 papers in Organic Chemistry. Recurrent topics in John W. Boja's work include Neurotransmitter Receptor Influence on Behavior (38 papers), Neuroscience and Neuropharmacology Research (25 papers) and Receptor Mechanisms and Signaling (18 papers). John W. Boja is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (38 papers), Neuroscience and Neuropharmacology Research (25 papers) and Receptor Mechanisms and Signaling (18 papers). John W. Boja collaborates with scholars based in United States, Bulgaria and France. John W. Boja's co-authors include Anita H. Lewin, Michael J. Kuhar, M J Kuhar, Philip Abraham, F. Ivy Carroll, F. Ivy Carroll, Yigong Gao, F. Ivy Carroll, Michael A. Kuzemko and M. Abdur Rahman and has published in prestigious journals such as Circulation Research, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

John W. Boja

52 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John W. Boja United States	28	1.6k	1.2k	443	262	160	53	2.3k
Peter C. Meltzer United States	24	853 0.5×	547 0.5×	470 1.1×	230 0.9×	209 1.3×	61	1.8k
Stephen M. Husbands United Kingdom	33	2.5k 1.6×	2.7k 2.3×	419 0.9×	112 0.4×	179 1.1×	157	4.0k
John L. Musachio United States	31	1.2k 0.8×	1.8k 1.5×	259 0.6×	147 0.6×	627 3.9×	80	3.0k
Alexey G. Mukhin United States	33	1.5k 1.0×	2.3k 2.0×	377 0.9×	166 0.6×	120 0.8×	76	3.4k
David E. Nichols United States	20	1.7k 1.1×	1.6k 1.4×	341 0.8×	107 0.4×	103 0.6×	50	2.5k
Gilles Tamagnan United States	36	1.7k 1.1×	1.9k 1.6×	547 1.2×	504 1.9×	502 3.1×	150	4.1k
S. Wayne Mascarella United States	25	1.4k 0.9×	1.8k 1.5×	626 1.4×	29 0.1×	115 0.7×	98	2.7k
Nora S. Kula United States	24	867 0.6×	658 0.6×	261 0.6×	209 0.8×	146 0.9×	70	1.5k
Mei‐Ping Kung United States	37	1.4k 0.9×	1.1k 0.9×	340 0.8×	577 2.2×	1.2k 7.5×	96	3.9k
Alice L. Rodriguez United States	32	1.9k 1.2×	2.1k 1.8×	610 1.4×	75 0.3×	83 0.5×	117	3.2k

Countries citing papers authored by John W. Boja

Since Specialization

Citations

This map shows the geographic impact of John W. Boja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Boja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Boja more than expected).

Fields of papers citing papers by John W. Boja

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Boja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Boja. The network helps show where John W. Boja may publish in the future.

Co-authorship network of co-authors of John W. Boja

This figure shows the co-authorship network connecting the top 25 collaborators of John W. Boja. A scholar is included among the top collaborators of John W. Boja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John W. Boja. John W. Boja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boja, John W., et al.. (1998). Inhibition of striatal dopamine transporter activity by 17β-estradiol. European Journal of Pharmacology. 345(2). 207–211. 93 indexed citations

Lever, John R., Ursula Scheffel, Marigo Stathis, et al.. (1996). Synthesis and in vivo studies of a selective ligand for the dopamine transporter: 3β-(4-[125I]iodophenyl) tropan-2β-carboxylic acid isopropyl ester ([125I]RTM-21). Nuclear Medicine and Biology. 23(3). 277–284. 18 indexed citations

Kotian, Pravin L., Anita H. Lewin, S. Wayne Mascarella, et al.. (1995). Synthesis and Ligand Binding Study of 3.beta.-(4'-Substituted phenyl)-2.beta.-(heterocyclic)tropanes. Journal of Medicinal Chemistry. 38(18). 3451–3453. 20 indexed citations

Carroll, F. Ivy, Pravin L. Kotian, Ali Dehghani, et al.. (1995). Cocaine and 3.beta.-(4'-Substituted phenyl)tropane-2.beta.-carboxylic Acid Ester and Amide Analogs. New High-Affinity and Selective Compounds for the Dopamine Transporter. Journal of Medicinal Chemistry. 38(2). 379–388. 171 indexed citations

Boja, John W., et al.. (1994). Secondary Amine Analogs of 3.beta.-(4'-Substituted phenyl)tropane-2.beta.-carboxylic Acid Esters and N-Norcocaine Exhibit Enhanced Affinity for Serotonin and Norepinephrine Transporters. Journal of Medicinal Chemistry. 37(8). 1220–1223. 66 indexed citations

Carroll, F. Ivy, S. Wayne Mascarella, Michael A. Kuzemko, et al.. (1994). Synthesis, Ligand Binding, and QSAR (CoMFA and Classical) Study of 3.beta.-(3'-Substituted phenyl)-, 3.beta.-(4'-Substituted phenyl)-, and 3.beta.-(3',4'-Disubstituted phenyl)tropane-2.beta.-carboxylic Acid Methyl Esters. Journal of Medicinal Chemistry. 37(18). 2865–2873. 93 indexed citations

Brouard, Aline, Didier Pélaprat, John W. Boja, et al.. (1993). Potent cocaine analogs inhibit [3H]dopamine uptake in rat mesencephalic cells in primary cultures: pharmacological selectivity of embryonic cocaine sites. Developmental Brain Research. 75(1). 13–17. 7 indexed citations

Abraham, Philip, J. Bruce Pitner, Anita H. Lewin, et al.. (1992). N-Modified analogs of cocaine: synthesis and inhibition of binding to the cocaine receptor. Journal of Medicinal Chemistry. 35(1). 141–144. 61 indexed citations

Cline, Elizabeth J., Ursula Scheffel, John W. Boja, et al.. (1992). In vivo binding of [¹²⁵I] RTI‐55 to dopamine transporters: Pharmacology and regional distribution with autoradiography. Synapse. 12(1). 37–46. 60 indexed citations

10.

Carroll, F. Ivy, Yigong Gao, Philip Abraham, et al.. (1992). Probes for the cocaine receptor. Potentially irreversible ligands for the dopamine transporter. Journal of Medicinal Chemistry. 35(10). 1813–1817. 47 indexed citations

11.

Carroll, F. Ivy, et al.. (1992). Isopropyl and phenyl esters of 3.beta.-(4-substituted phenyl)tropan-2.beta.-carboxylic acids. Potent and selective compounds for the dopamine transporter. Journal of Medicinal Chemistry. 35(13). 2497–2500. 67 indexed citations

12.

Lew, Robert, et al.. (1991). Dopamine transporter: deglycosylation with exo- and endoglycosidases. Brain Research. 539(2). 239–246. 43 indexed citations

13.

Carroll, F. Ivy, Yigong Gao, M. Abdur Rahman, et al.. (1991). Synthesis, ligand binding, QSAR, and CoMFA study of 3.beta.-(p-substituted phenyl)tropane-2.beta.-carboxylic acid methyl esters. Journal of Medicinal Chemistry. 34(9). 2719–2725. 133 indexed citations

14.

Carroll, F. Ivy, et al.. (1991). Synthesis and ligand binding of cocaine isomers at the cocaine receptor. Journal of Medicinal Chemistry. 34(3). 883–886. 57 indexed citations

15.

Boja, John W., Amrat Patel, M. Abdur Rahman, et al.. (1991). [125I]RTI-55: a potent ligand for dopamine transporters. European Journal of Pharmacology. 194(1). 133–134. 119 indexed citations

16.

Boja, John W., et al.. (1990). Increased drug sensitivity in the drug discrimination procedure afforded by drug versus drug training. Psychopharmacology. 102(2). 221–226. 6 indexed citations

17.

Boja, John W., et al.. (1990). New, potent cocaine analogs: ligand binding and transport studies in rat striatum. European Journal of Pharmacology. 184(2-3). 329–332. 64 indexed citations

18.

Scheffel, Ursula, John W. Boja, & Michael J. Kuhar. (1989). Cocaine receptors: In vivo labeling with ³H‐(—)cocaine, ³H‐win 35,065‐2, and ³H‐win 35,428. Synapse. 4(4). 390–392. 52 indexed citations

19.

Schechter, Martin & John W. Boja. (1988). Lack of generalization of nisoxetine with amphetamine in the rat. Pharmacology Biochemistry and Behavior. 30(4). 1085–1088. 7 indexed citations

20.

Schechter, Martin & John W. Boja. (1988). CGS 10746B is able to attenuate the effects of amphetamine: Further evidence for dopaminergic mediation. Pharmacology Biochemistry and Behavior. 30(4). 1089–1092. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact